COMMITTEE on WAYS and MEANS

Chairman Dave Camp

Calendar Item

Boustany Announces Hearing on the Impact of Limitations on the Use of Tax-Advantaged Accounts for the Purchase of Over-the-Counter Medication

Apr 25, 2012


Focus Of The Hearing:
The hearing will focus on reviewing the rules affecting FSAs, HSAs and HRAs and the impact the rules have on consumers, physicians, and employers. 

Hearing Advisory:
Boustany Announces Hearing on the Impact of Limitations on the Use of Tax-Advantaged Accounts for the Purchase of Over-the-Counter Medication

Witness List:

Mr. Scott M. Melville
President & Chief Executive Officer, Consumer Healthcare Products Association
Testimony
(Truth in Testimony)

Dr. Joel M. Feder
D.O., F.A.C.O.F.P., Captain MC, USN (Ret.), American Osteopathic Association
Testimony
(Truth in Testimony)

Mr. Steven Taylor
Chief Executive Officer, Sjogren’s Syndrome Foundation
Testimony
(Truth in Testimony)

Ms. Jennifer Hatcher
Senior Vice President, Government & Public Affairs, Food Marketing Institute
Testimony
(Truth in Testimony)

Mr. Paul N. Van de Water
Senior Fellow, Center on Budget and Policy Priorities
Testimony
(Truth in Testimony)


Transcript